ArticleScientific reports2025
Inflammatory markers including NLR, AFR and SII as prognostic factors in neuroblastoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Bibliometric analysis of knowledge maps and future trends of TIM-3 in cancer.Frontiers in oncology · 2026Pooled it
- Article
- Body mass index mediates the association between neutrophil-to-lymphocyte ratio and impaired fasting glucose: evidence from a five-year follow-up study.Scientific reports · 2026Article
- Systemic inflammatory indices and lung cancer risk by smoking and alcohol use in Korean men: A secondary dataset analysis of the Korean Cancer Prevention Study-II.Tobacco induced diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Neuroblastoma (NB) is a common pediatric solid tumor, particularly in children under 2 years. While survival rates for low- and intermediate-risk NB have improved, the prognosis for high-risk patients remains poor. Inflammation plays a crucial role in tumor progression, and systemic inflammation markers have prognostic value in various cancers. This study investigates the prognostic significance of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), and albumin-to-fibrinogen ratio (AFR) in NB patients. A retrospective analysis was conducted on 166 NB patients diagnosed between January 2013 and November 2024 at Hebei Provincial Children's Hospital. Preoperative blood parameters, including neutrophil, lymphocyte, platelet counts, albumin, and fibrinogen levels, were used to calculate NLR, SII, and AFR. ROC curves assessed the relationship between these markers and patient outcomes. Kaplan-Meier survival analysis and Cox regression were performed to evaluate their prognostic value. NLR and SII had high predictive value for mortality, with ROC AUCs of 0.90 and 0.89, respectively. AFR had lower predictive value (AUCs of 0.73 and 0.74). Kaplan-Meier analysis showed that high NLR, low AFR, and high SII correlated with poorer overall survival (OS) and event-free survival (EFS). Both univariate and multivariate Cox regression identified NLR and SII as independent risk factors for OS and EFS. This study demonstrates the prognostic value of NLR, SII, and AFR in the evaluation of NB prognosis, particularly highlighting the efficacy of NLR and SII in predicting mortality and recurrence risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.